Boston-based biotechnology company Zageno has secured $20 million in Series B funding, according to company database Crunchbase, topping the city’s recent funding headlines. The cash infusion was announced April 23 and led by General Catalyst.
According to its Crunchbase profile, "Zageno, Inc. has become the world's largest marketplace for life science products. By integrating the needs of researchers, laboratories, procurement departments and vendors into one single solution. Zageno's online marketplace for life-science research enables straightforward integration of ordering and purchasing processes into existing software systems."
The four-year-old startup has raised two previous funding rounds, including an $8 million Series A round in 2017.
The round brings total funding raised by Boston companies in commerce and shopping over the past month to $599 million. The local commerce and shopping industry has seen 31 funding rounds over the past year, raking in a total of $1 billion in venture funding.
In other local funding news, risk-management company Censinet announced a $7.8 million Series A funding round on April 22, led by Cedars Sinai Medical Center.
According to Crunchbase, "Censinet fundamentally redefines the way vendor risk is managed in healthcare. Unlike other solutions, Censinet not only streamlines and simplifies workflows, but also standardizes risk questions with breadth and accuracy of risk ratings. Only Censinet was developed exclusively by and for healthcare providers, which makes Censinet the first and only collaborative cloud platform for vendor risk management."
Founded in 2017, the company has raised two previous rounds, including a $500,000 round in 2018.